Concepedia

Nishi Shah

NS

Statistics

Publications

27

Citations

1.1K

H-Index

16

Active since

2010

Affiliations

Albert Einstein College of Medicine(Current)

Montefiore Medical Center

University of Arkansas for Medical Sciences

Cornell University

Memorial Sloan Kettering Cancer Center

Nishi Shah is an author at Albert Einstein College of Medicine specializing in medicine, oncology, and cancer immunotherapy.

ORCID

Publications per year

2010–2025

27

Publications

27

Axicabtagene ciloleucel CD19 CAR-T cell therapy results in high rates of systemic and neurologic remissions in ten patients with refractory large B cell lymphoma including two with HIV and viral hepatitis

Stephen Peeke, Nishi Shah, Jennat Mustafa et al. · Journal of Hematology & Oncology · 2020 · 210 citations · Full text

, , +9

PARP1 Is Up-Regulated in Non-small Cell Lung Cancer Tissues in the Presence of the Cyanobacterial Toxin Microcystin

Patrick L. Apopa, Lisa Alley, Rosalind B. Penney et al. · Frontiers in Microbiology · 2018 · 128 citations · Full text

, , +6

Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphoma

Ana Alarcón Tomás, Joshua Fein, Shalev Fried et al. · Leukemia · 2022 · 102 citations · Full text

, , +13

Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study

Meera Mohan, Jorge Monge, Nishi Shah et al. · Blood Cancer Journal · 2024 · 97 citations · Full text

, , +16

Activation of targetable inflammatory immune signaling is seen in myelodysplastic syndromes with SF3B1 mutations

Gaurav S. Choudhary, Andrea Pellagatti, Bogos Agianian et al. · eLife · 2022 · 73 citations · Full text

, , +17

1–5 of 27